Iovance Biotherapeutics, Inc.
IOVA
Revenue
86.77M
▲19.32M▲28.64%
3 Months ChangeAssets
913.17M
▲8.22M▲0.9086%
3 Months ChangeLiabilities
214.59M
▲11.93M▲5.88%
3 Months ChangeFree Cash Flow
-109.91M
▲16.55M▲13.08%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-02-24
Form 8-K
ID: 0001104659-26-018837
2026-01-09
Form 8-K
ID: 0001104659-26-002323
2025-11-06
Form 10-Q
ID: 0001104659-25-107470
2025-11-06
Form 8-K
ID: 0001104659-25-107426
2025-08-29
Form 8-K
ID: 0001104659-25-085650
2025-08-22
Form 8-K
ID: 0001104659-25-081953
2025-08-19
Form 8-K
ID: 0001104659-25-080304
2025-08-07
Form 10-Q
ID: 0001558370-25-010807
2025-08-07
Form 8-K
ID: 0001104659-25-075175
2025-07-15
Form 8-K
ID: 0001104659-25-067940